Skip to main content

Test Price

3,600 AED

✅ Home Collection Available

Colorectal Cancer Panel (NRAS, KRAS, BRAF) in UAE | 3600 AED | DNA Labs UAE

Clinical Certainty: 99.9% Diagnostic Sensitivity

ISO 9001:2015 accredited processing with dual NGS + Sanger confirmation ensures every mutation call is clinically actionable. Sample integrity maintained via validated cold-chain logistics for solid tumor tissue.

🏠Secure Medical Courier Solid Tissue Specimen Retrieval (FFPE block or fresh tumor biopsy)
🧬Post‑Test Telephonic Guidance: board‑certified oncologist interpretation.
📋Insurance Direct Billing: WhatsApp +971 54 548 8731 for pre‑approval.
🏥DHA‑licensed facility (License No. 1143), Mr. Prabhakar Reddy Kalathoor (DHA: 61713011).

Test Overview & Methodology

The Colorectal Cancer Panel profiles three critical oncogenes — NRAS, KRAS, and BRAF — directly from your tumor tissue. This panel is essential for determining the right targeted therapy plan for colorectal cancer, increasing response chances and avoiding ineffective drug side effects.

FeatureOur Test (DNA Labs UAE)Closest Alternative
PrecisionNGS + Sanger orthogonal validationSanger only (single‑gene bias)
Turnaround7–8 days10–14 days
Price3600 AED (inclusive of counselling)4500–5000 AED (counselling extra)
ISO AccreditationISO 9001:2015 (Cert: INT/EGQ/2509DA/3139)Often uncertified

Physician Insight & Safety Protocols

“This panel is the cornerstone of anti‑EGFR therapy selection. As a specialist in diagnostic radiology, I rely on these results to guide clinicians in sparing patients from futile treatments and tailoring biologics precisely. Always correlate with full histological and imaging findings.” – Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology (DHA: 61713011).

Clinical Advisory

Do not discontinue or modify any prescribed medication (including chemotherapy, targeted agents, or supportive care) based solely on this test result. Always consult your treating oncologist for interpretation and treatment decisions.

Exclusion Criteria & Red Flags

  • Unsuitable for patients with non‑colorectal primary tumors; panel is validated only for colorectal adenocarcinoma.
  • Tissue sample must be a formalin‑fixed paraffin‑embedded (FFPE) block or fresh tumor biopsy; cytology specimens are not accepted.
  • Emergency Alert: If you experience rectal bleeding, severe abdominal pain, or signs of infection at the biopsy site, go to the nearest emergency department immediately.

Patient FAQ & Clinical Guidance

1. What does the colorectal cancer panel detect, and how is the sample collected?

This panel identifies mutations in NRAS, KRAS, and BRAF genes that predict response to anti‑EGFR therapies. A small piece of your tumor tissue, obtained during biopsy or surgery and preserved in a formalin‑fixed paraffin‑embedded block, is sent under cold‑chain to our molecular lab via secure medical courier.

2. How long does it take to get results, and is any preparation required?

The final report is issued within 7–8 working days. No fasting or special preparation is needed as the test is performed on previously collected tumor tissue.

3. Why is this panel crucial before starting targeted therapy?

Without this, anti‑EGFR drugs like cetuximab or panitumumab are ineffective and potentially harmful for RAS‑mutant tumors. The panel ensures treatment is personalized, maximizing benefit and minimizing toxicity.

UAE Regulatory & Data Privacy Adherence

Compliance & Data Protection

This service complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL), Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, and Federal Decree‑Law No. 4 of 2016 on Medical Liability. ISO 9001:2015 certification guarantees process quality and data security.

Clinical & Logistical Metadata

Test Name Colorectal Cancer Panel (NRAS, KRAS, BRAF)
Price (AED) 3,600
Turnaround Time 7–8 working days
Sample Type / Matrix Formalin‑fixed paraffin‑embedded (FFPE) tissue block or fresh tumor biopsy
Methodology Used Next‑Generation Sequencing (NGS) + Sanger sequencing orthogonal validation
ICD-10-CM Code C18.9, C19, C20
LOINC Code 101596-7
DHA Facility License & Laboratory Address License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians